NL-OMON32065已完成3 期
Efficacy and Safety of Quadruple Therapy by Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline Given x 10 days With Omeprazole in Eradication of Helicobacter pylori: A Comparison to Omeprazole, Amoxicillin and Clarithromycin Given x 7 days - PYLHp07-01
Axcan Pharma0 个研究点目标入组 16 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •-Male or non-pregnant, non-nursing female, 18 years of age and older
- •-Positive for Helicobacter pylori by both C-13 UBT and at least two of three positive results among rapid urease test, histologic examination and/or culture
- •-Presence of upper gastrointestinal symptoms
排除标准
- •-Previous surgery of the upper gastrointestinal tract (except appendectomy, polypectomy, or cholecystectomy)
- •-Any current or recent (within 1 month of screening) hematemesis, melena, or documented gastrointestinal bleeding or iron-deficiency anaemia of clinical significance
- •-Barrett*s esophagus or high-grade dysplasia
- •-Dysphagia or vomiting as major symptoms
- •-Previous attempt by a recognized antibiotic treatment to eradicate an adequately documented infection by Helicobacter pylori.
研究者
相似试验
进行中（未招募）
不适用
Efficacy and Safety of Quadruple Therapy by Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline Given x 10 days With Omeprazole in Eradication of Helicobacter pylori: A Comparison to Omeprazole, Amoxicillin and Clarithromycin Given x 7 daysMedDRA version: 9.1Level: HLTClassification code 10019375Term: Helicobacter infectionsHelicobacter pylori infectionEUCTR2007-006280-78-IEAxcan Pharma Inc.400
进行中（未招募）
1 期
Efficacy and Safety of Quadruple Therapy by Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline Given x 10 days With Omeprazole in Eradication of Helicobacter pylori: A Comparison to Omeprazole, Amoxicillin and Clarithromycin Given x 7 daysHelicobacter pylori infectionEUCTR2007-006280-78-FRAxcan Pharma Inc.400
进行中（未招募）
不适用
Efficacy and Safety of Quadruple Therapy by Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline Given x 10 days With Omeprazole in Eradication of Helicobacter pylori: A Comparison to Omeprazole, Amoxicillin and Clarithromycin Given x 7 daysMedDRA version: 9.1Level: HLTClassification code 10019375Term: Helicobacter infectionsHelicobacter pylori infectionEUCTR2007-006280-78-PLAxcan Pharma Inc.400
进行中（未招募）
不适用
Efficacy and Safety of Quadruple Therapy by Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline Given x 10 days With Omeprazole in Eradication of Helicobacter pylori: A Comparison to Omeprazole, Amoxicillin and Clarithromycin Given x 7 daysHelicobacter pylori infectionEUCTR2007-006280-78-NLAxcan Pharma Inc.400
进行中（未招募）
不适用
Efficacy and Safety of Quadruple Therapy by Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline Given x 10 days With Omeprazole in Eradication of Helicobacter pylori: A Comparison to Omeprazole, Amoxicillin and Clarithromycin Given x 7 daysMedDRA version: 9.1Level: HLTClassification code 10019375Term: Helicobacter infectionsHelicobacter pylori infectionEUCTR2007-006280-78-DEAxcan Pharma Inc.400